3 stories
AI briefings + tags; source links are the ground truth.
About
🇦🇷
Argentina
Clarin (ES)
National & Local
The Ozempic patent falls in the largest countries, prices drop, and previously unknown data comes to light
The expiration of the Ozempic patent in populous countries like India and China paves the way for cheaper generic versions of GLP-1 medications, significantly impacting global health.
Mar 18 • 09:01 UTC
🇵🇱
Poland
Rzeczpospolita
National & Local
The patent for the most expensive diabetes drug has been revoked. Are cheaper alternatives closer to reimbursement?
A patent for dapagliflozin, a leading diabetes medication, has been revoked, potentially paving the way for cheaper generic versions to be reimbursed in Poland.
Feb 17 • 18:44 UTC
🇬🇷
Greece
Proto Thema
Life & Tech
The Patents for Weight Loss Drugs Expire: Generics Are Coming
The expiration of patents for weight loss drugs is paving the way for the introduction of generic alternatives in the global obesity medication market.
Jan 7 • 06:56 UTC